{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T01:29:10Z","timestamp":1790386150386,"version":"4.1.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T00:00:00Z","timestamp":1756252800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T00:00:00Z","timestamp":1756252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"QNRF Rapid Response Grant","award":["RRC02\u20100810\u2010210032"],"award-info":[{"award-number":["RRC02\u20100810\u2010210032"]}]},{"name":"QNRF Rapid Response Grant","award":["RRC02\u20100810\u2010210032"],"award-info":[{"award-number":["RRC02\u20100810\u2010210032"]}]},{"name":"QNRF Rapid Response Grant","award":["RRC02\u20100810\u2010210032"],"award-info":[{"award-number":["RRC02\u20100810\u2010210032"]}]},{"name":"QNRF Rapid Response Grant","award":["RRC02\u20100810\u2010210032"],"award-info":[{"award-number":["RRC02\u20100810\u2010210032"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11322-6","type":"journal-article","created":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T05:39:59Z","timestamp":1756273199000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Dexamethasone chronotherapy of COVID-19 patients admitted to intensive care unit: an exploratory study"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0955-0055","authenticated-orcid":false,"given":"Mohammad","family":"Abusamak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7764-5793","authenticated-orcid":false,"given":"Ali","family":"Ait Hssain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkateswara Rao","family":"Chinta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5090-5084","authenticated-orcid":false,"given":"Haider","family":"Al-Waeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7592-2788","authenticated-orcid":false,"given":"Hadi M.","family":"Yassine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4618-8374","authenticated-orcid":false,"given":"Faleh","family":"Tamimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,27]]},"reference":[{"issue":"1","key":"11322_CR1","first-page":"1","volume":"7","author":"YR Guo","year":"2020","unstructured":"Guo YR, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak\u2013an update on the status. Mil Med Res. 2020;7(1):1\u201310.","journal-title":"Mil Med Res"},{"issue":"1","key":"11322_CR2","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1080\/22221751.2020.1736644","volume":"9","author":"SY Fung","year":"2020","unstructured":"Fung SY, et al. A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses. Emerg Microbes Infect. 2020;9(1):558\u201370.","journal-title":"Emerg Microbes Infect"},{"key":"11322_CR3","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/j.1365-2249.2004.02415.x","volume":"136","author":"C Wong","year":"2004","unstructured":"Wong C, et al. Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome. Clin Exp Immunol. 2004;136:95\u2013103.","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"11322_CR4","doi-asserted-by":"publisher","first-page":"327","DOI":"10.23812\/CONTI-E","volume":"34","author":"PR Conti","year":"2020","unstructured":"Conti PR, Ronconi G, Caraffa AL, Gallenga CE, Ross R, Frydas I, Kritas SK. Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies. J Biol Regul Homeost Agents. 2020;34(2):327\u201331. https:\/\/doi.org\/10.23812\/CONTI-E.","journal-title":"J Biol Regul Homeost Agents"},{"issue":"1","key":"11322_CR5","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1186\/s12879-024-09205-3","volume":"24","author":"H Liu","year":"2024","unstructured":"Liu H, et al. Association of interleukin-6, ferritin, and lactate dehydrogenase with venous thromboembolism in COVID-19: a systematic review and meta-analysis. BMC Infect Dis. 2024;24(1):324.","journal-title":"BMC Infect Dis"},{"issue":"10229","key":"11322_CR6","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","volume":"395","author":"P Mehta","year":"2020","unstructured":"Mehta P, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033.","journal-title":"Lancet"},{"issue":"1","key":"11322_CR7","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s12879-024-09056-y","volume":"24","author":"O Aljuhani","year":"2024","unstructured":"Aljuhani O, et al. Dexamethasone versus methylprednisolone for multiple organ dysfunction in COVID-19 critically ill patients: a multicenter propensity score matching study. BMC Infect Dis. 2024;24(1):189.","journal-title":"BMC Infect Dis"},{"key":"11322_CR8","doi-asserted-by":"publisher","unstructured":"RECOVERY Collaborative Group, Chappell L, Horby P, Shen Lim W, Emberson JR, Mafham M et al. Dexamethasone in Hospitalized Patients with Covid-19 - Preliminary Report. The New England Journal of Medicine. 2020 Jul 17. Epub 2020 Jul 17. https:\/\/doi.org\/10.1056\/NEJMoa2021436.","DOI":"10.1056\/NEJMoa2021436"},{"issue":"8","key":"11322_CR9","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJMoa2021436","volume":"384","author":"RECOVERY Collaborative Group","year":"2021","unstructured":"RECOVERY Collaborative Group. Dexamethasone in hospitalized patients with Covid-19. New England journal of medicine. 2021;384(8):693\u2013704. https:\/\/doi.org\/10.1056\/NEJMoa2021436.","journal-title":"New England journal of medicine"},{"issue":"16","key":"11322_CR10","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1056\/NEJMra050541","volume":"353","author":"T Rhen","year":"2005","unstructured":"Rhen T, Cidlowski JA. Antiinflammatory action of glucocorticoids\u2014new mechanisms for old drugs. N Engl J Med. 2005;353(16):1711\u201323.","journal-title":"N Engl J Med"},{"key":"11322_CR11","doi-asserted-by":"publisher","unstructured":"Horby P, Lim WS, Emberson J, Mafham M, Bell J, Linsell L, Staplin N, Brightling C, Ustianowski A, Elmahi E, Prudon B. Effect of dexamethasone in hospitalized patients with COVID-19\u2013preliminary report. MedRxiv. 2020:2020\u201306.\u00a0https:\/\/doi.org\/10.1101\/2020.06.22.20137273.","DOI":"10.1101\/2020.06.22.20137273"},{"key":"11322_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102567","volume":"19","author":"Y Jamilloux","year":"2020","unstructured":"Jamilloux Y, et al. Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions. Autoimmun Rev. 2020;19: 102567.","journal-title":"Autoimmun Rev"},{"key":"11322_CR13","doi-asserted-by":"publisher","unstructured":"Penman SL, Kiy RT, Jensen RL, Beoku\u2010Betts C, Alfirevic A, Back D, Khoo SH, Owen A, Pirmohamed M, Park BK, Meng X. Safety perspectives on presently considered drugs for the treatment of COVID\u201019. British Journal of Pharmacology. 2020;177(19):4353\u201374.\u00a0https:\/\/doi.org\/10.1111\/bph.15204.","DOI":"10.1111\/bph.15204"},{"key":"11322_CR14","doi-asserted-by":"publisher","unstructured":"Thoguluva Chandrasekar V, Venkatesalu B, Patel HK, Spadaccini M, Manteuffel J, Ramesh M. Systematic review and meta\u2010analysis of effectiveness of treatment options against SARS\u2010CoV\u20102 infection. Journal of Medical Virology. 2021;93(2):775-85.\u00a0https:\/\/doi.org\/10.1002\/jmv.26302.","DOI":"10.1002\/jmv.26302"},{"issue":"2","key":"11322_CR15","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1590\/S0100-879X2005000200003","volume":"38","author":"A Fernandes","year":"2005","unstructured":"Fernandes A, Zin W, Rocco P. Corticosteroids in acute respiratory distress syndrome. Braz J Med Biol Res. 2005;38(2):147\u201359.","journal-title":"Braz J Med Biol Res"},{"issue":"2","key":"11322_CR16","first-page":"147","volume":"9","author":"P Hart","year":"1990","unstructured":"Hart P, et al. Augmentation of glucocorticoid action on human monocytes by interleukin-4. Lymphokine Res. 1990;9(2):147\u201353.","journal-title":"Lymphokine Res"},{"issue":"2","key":"11322_CR17","first-page":"121","volume":"25","author":"CW Lam","year":"2004","unstructured":"Lam CW, Chan MH, Wong CK. Severe acute respiratory syndrome: clinical and laboratory manifestations. Clin Biochem Rev. 2004;25(2):121.","journal-title":"Clin Biochem Rev"},{"issue":"4","key":"11322_CR18","doi-asserted-by":"publisher","first-page":"S253","DOI":"10.1097\/01.CCM.0000057900.19201.55","volume":"31","author":"BT Thompson","year":"2003","unstructured":"Thompson BT. Glucocorticoids and acute lung injury. Crit Care Med. 2003;31(4):S253\u20137.","journal-title":"Crit Care Med"},{"issue":"2","key":"11322_CR19","doi-asserted-by":"publisher","first-page":"e98","DOI":"10.1097\/CCM.0000000000004093","volume":"48","author":"LE Lansbury","year":"2020","unstructured":"Lansbury LE, et al. Corticosteroids as adjunctive therapy in the treatment of influenza: an updated Cochrane systematic review and meta-analysis. Crit Care Med. 2020;48(2):e98\u2013106.","journal-title":"Crit Care Med"},{"issue":"6","key":"11322_CR20","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1177\/1078155220931921","volume":"26","author":"MA Marinella","year":"2020","unstructured":"Marinella MA. Routine antiemetic prophylaxis with dexamethasone during COVID-19: should oncologists reconsider? J Oncol Pharm Pract. 2020;26(6):1482\u20135. https:\/\/doi.org\/10.1177\/1078155220931921.","journal-title":"J Oncol Pharm Pract"},{"issue":"2","key":"11322_CR21","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1097\/CCM.0000000000001402","volume":"44","author":"B Shakoory","year":"2016","unstructured":"Shakoory B, et al. Interleukin-1 receptor blockade is associated with reduced mortality in sepsis patients with features of the macrophage activation syndrome: re-analysis of a prior phase III trial. Crit Care Med. 2016;44(2):275.","journal-title":"Crit Care Med"},{"issue":"20","key":"11322_CR22","doi-asserted-by":"publisher","first-page":"10970","DOI":"10.1073\/pnas.2005615117","volume":"117","author":"X Xu","year":"2020","unstructured":"Xu X, et al. Effective treatment of severe COVID-19 patients with tocilizumab. Proc Natl Acad Sci. 2020;117(20):10970\u20135.","journal-title":"Proc Natl Acad Sci"},{"key":"11322_CR23","doi-asserted-by":"publisher","unstructured":"Zhou Q, Chen V, Shannon CP, Wei X-S, Xiang X, Wang X, Wang Z-H, Tebbutt SJ, Kollmann TR and Fish EN (2020) Interferon-\u20022b Treatment for COVID-19. Front. Immunol. 11:1061. https:\/\/doi.org\/10.3389\/fimmu.2020.01061.","DOI":"10.3389\/fimmu.2020.01061"},{"issue":"1","key":"11322_CR24","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jaci.2020.05.019","volume":"146","author":"Y Cao","year":"2020","unstructured":"Cao Y, et al. Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): a multicenter, single-blind, randomized controlled trial. J Allergy Clin Immunol. 2020;146(1):137\u201346. https:\/\/doi.org\/10.1016\/j.jaci.2020.05.019.","journal-title":"J Allergy Clin Immunol"},{"key":"11322_CR25","unstructured":"COVID-19 Treatment Guidelines Panel. Coronavirus disease 2019 (COVID-19) treatment guidelines. National Institutes of Health. Available at https:\/\/www.covid19treatmentguidelines.nih.gov\/. Accessed 11Sep 2020."},{"key":"11322_CR26","doi-asserted-by":"publisher","first-page":"277","DOI":"10.2147\/NSS.S151525","volume":"9","author":"Y Boyko","year":"2017","unstructured":"Boyko Y, Jennum P, Toft P. Sleep quality and circadian rhythm disruption in the intensive care unit: a review. Nat Sci Sleep. 2017;9:277.","journal-title":"Nat Sci Sleep"},{"key":"11322_CR27","doi-asserted-by":"publisher","unstructured":"Silva, F. R. da, Guerreiro, R. de C., Andrade, H. de A., Stieler, E., Silva, A., & de Mello, M. T. Does the compromised sleep and circadian disruption of night and shiftworkers make them highly vulnerable to 2019 coronavirus disease (COVID-19)? Chronobiology International. 2020;37(5):607\u2013617.\u00a0https:\/\/doi.org\/10.1080\/07420528.2020.1756841.","DOI":"10.1080\/07420528.2020.1756841"},{"issue":"6315","key":"11322_CR28","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1126\/science.aah4966","volume":"354","author":"K Man","year":"2016","unstructured":"Man K, Loudon A, Chawla A. Immunity around the clock. Science. 2016;354(6315):999\u20131003.","journal-title":"Science"},{"issue":"36","key":"11322_CR29","doi-asserted-by":"publisher","first-page":"10085","DOI":"10.1073\/pnas.1601895113","volume":"113","author":"RS Edgar","year":"2016","unstructured":"Edgar RS, et al. Cell autonomous regulation of herpes and influenza virus infection by the circadian clock. Proc Natl Acad Sci. 2016;113(36):10085\u201390.","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"11322_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-019-11400-9","volume":"10","author":"S Sengupta","year":"2019","unstructured":"Sengupta S, et al. Circadian control of lung inflammation in influenza infection. Nat Commun. 2019;10(1):1\u201313.","journal-title":"Nat Commun"},{"issue":"12","key":"11322_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0029801","volume":"6","author":"T Bollinger","year":"2011","unstructured":"Bollinger T, et al. Circadian clocks in mouse and human CD4+ T cells. PLoS One. 2011;6(12): e29801.","journal-title":"PLoS One"},{"issue":"40","key":"11322_CR32","doi-asserted-by":"publisher","first-page":"20077","DOI":"10.1073\/pnas.1905080116","volume":"116","author":"CC Nobis","year":"2019","unstructured":"Nobis CC, et al. The circadian clock of CD8 T cells modulates their early response to vaccination and the rhythmicity of related signaling pathways. Proc Natl Acad Sci. 2019;116(40):20077\u201386.","journal-title":"Proc Natl Acad Sci"},{"issue":"21","key":"11322_CR33","doi-asserted-by":"publisher","first-page":"5134","DOI":"10.1182\/blood-2008-11-190769","volume":"113","author":"S Dimitrov","year":"2009","unstructured":"Dimitrov S, et al. Cortisol and epinephrine control opposing circadian rhythms in T cell subsets. Blood. 2009;113(21):5134\u201343.","journal-title":"Blood"},{"issue":"3","key":"11322_CR34","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1159\/000084844","volume":"12","author":"AN Vgontzas","year":"2005","unstructured":"Vgontzas AN, et al. IL-6 and its circadian secretion in humans. Neuroimmunomodulation. 2005;12(3):131\u201340.","journal-title":"Neuroimmunomodulation"},{"issue":"1","key":"11322_CR35","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3109\/07420529509064496","volume":"12","author":"MRI Young","year":"1995","unstructured":"Young MRI, et al. Circadian rhythmometry of serum interleukin-2, interleukin-10, tumor necrosis factor-\u03b1, and granulocyte-macrophage colony-stimulating factor in men. Chronobiol Int. 1995;12(1):19\u201327.","journal-title":"Chronobiol Int"},{"key":"11322_CR36","first-page":"38","volume":"21","author":"P Zabel","year":"1993","unstructured":"Zabel P, Linnemann K, Schlaak M. Circadian rhythm in cytokines. Immun Infekt. 1993;21:38\u201340.","journal-title":"Immun Infekt"},{"key":"11322_CR37","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.bbi.2014.11.003","volume":"47","author":"SA Rahman","year":"2015","unstructured":"Rahman SA, et al. Endogenous circadian regulation of pro-inflammatory cytokines and chemokines in the presence of bacterial lipopolysaccharide in humans. Brain Behav Immun. 2015;47:4\u201313.","journal-title":"Brain Behav Immun"},{"issue":"8","key":"11322_CR38","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1002\/jbmr.5650100818","volume":"10","author":"TA Einhorn","year":"1995","unstructured":"Einhorn TA, et al. The expression of cytokine activity by fracture callus. J Bone Miner Res. 1995;10(8):1272\u201381.","journal-title":"J Bone Miner Res"},{"issue":"9","key":"11322_CR39","doi-asserted-by":"publisher","first-page":"4454","DOI":"10.4049\/jimmunol.158.9.4454","volume":"158","author":"J Born","year":"1997","unstructured":"Born J, et al. Effects of sleep and circadian rhythm on human circulating immune cells. J Immunol. 1997;158(9):4454\u201364.","journal-title":"J Immunol"},{"issue":"6453","key":"11322_CR40","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1126\/science.aax7621","volume":"365","author":"MD Ruben","year":"2019","unstructured":"Ruben MD, et al. Dosing time matters. Science. 2019;365(6453):547\u20139.","journal-title":"Science"},{"issue":"6381","key":"11322_CR41","doi-asserted-by":"publisher","first-page":"eaao0318","DOI":"10.1126\/science.aao0318","volume":"359","author":"LS Mure","year":"2018","unstructured":"Mure LS, et al. Diurnal transcriptome atlas of a primate across major neural and peripheral tissues. Science. 2018;359(6381):eaao0318.","journal-title":"Science"},{"issue":"20","key":"11322_CR42","doi-asserted-by":"publisher","first-page":"5312","DOI":"10.1073\/pnas.1619320114","volume":"114","author":"RC Anafi","year":"2017","unstructured":"Anafi RC, et al. CYCLOPS reveals human transcriptional rhythms in health and disease. Proc Natl Acad Sci. 2017;114(20):5312\u20137.","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"11322_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-020-0694-0","volume":"10","author":"WH Walker","year":"2020","unstructured":"Walker WH, et al. Circadian rhythm disruption and mental health. Transl Psychiatry. 2020;10(1): 28.","journal-title":"Transl Psychiatry"},{"issue":"1","key":"11322_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/sleep\/4.1.1","volume":"4","author":"CA Czeisler","year":"1981","unstructured":"Czeisler CA, et al. Chronotherapy: resetting the circadian clocks of patients with delayed sleep phase insomnia. Sleep. 1981;4(1):1\u201321.","journal-title":"Sleep"},{"key":"11322_CR45","doi-asserted-by":"crossref","unstructured":"Telias I, Wilcox ME. Sleep and circadian rhythm in critical illness. In: Annual update in intensive care and emergency medicine 2019. Springer; 2019. p. 651\u2013664.","DOI":"10.1007\/978-3-030-06067-1_50"},{"issue":"9","key":"11322_CR46","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.tips.2018.07.003","volume":"39","author":"G Sulli","year":"2018","unstructured":"Sulli G, et al. Training the circadian clock, clocking the drugs, and drugging the clock to prevent, manage, and treat chronic diseases. Trends Pharmacol Sci. 2018;39(9):812\u201327.","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"11322_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-57215-y","volume":"10","author":"H Al-Waeli","year":"2020","unstructured":"Al-Waeli H, Nicolau B, Stone L, Abu Nada L, Gao Q, Abdallah MN, Abdulkader E, Suzuki M, Mansour A, Al Subaie A, Tamimi F. Chronotherapy of Non-Steroidal Anti-Inflammatory Drugs May Enhance Postoperative Recovery. Sci Rep. 2020 Jan 16;10(1):468. doi: 10.1038\/s41598-019-57215-y. PMID: 31949183; PMCID: PMC6965200.","journal-title":"Sci Rep"},{"key":"11322_CR48","doi-asserted-by":"publisher","unstructured":"Tamimi F, Abusamak M, Akkanti B, Chen Z, Yoo SH, Karmouty-Quintana H. The case for chronotherapy in Covid-19-induced acute respiratory distress syndrome. Br J Pharmacol. 2020;177(21):4845-4850. https:\/\/doi.org\/10.1111\/bph.15140. Epub 2020 Jul 3. PMID: 32442317; PMCID: PMC7280566.","DOI":"10.1111\/bph.15140"},{"issue":"1","key":"11322_CR49","doi-asserted-by":"publisher","first-page":"61","DOI":"10.2165\/00003088-200544010-00003","volume":"44","author":"D Czock","year":"2005","unstructured":"Czock D, et al. Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids. Clin Pharmacokinet. 2005;44(1):61\u201398.","journal-title":"Clin Pharmacokinet"},{"issue":"4","key":"11322_CR50","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/BF00618778","volume":"20","author":"S Miyabo","year":"1981","unstructured":"Miyabo S, et al. A comparison of the bioavailability and potency of dexamethasone phosphate and sulphate in man. Eur J Clin Pharmacol. 1981;20(4):277\u201382.","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"11322_CR51","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1177\/00912700122010285","volume":"41","author":"G Hochhaus","year":"2001","unstructured":"Hochhaus G, et al. Pharmacokinetics and pharmacodynamics of dexamethasone sodium-m-sulfobenzoate (DS) after intravenous and intramuscular administration: a comparison with dexamethasone phosphate (DP). J Clin Pharmacol. 2001;41(4):425\u201334.","journal-title":"J Clin Pharmacol"},{"issue":"3","key":"11322_CR52","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1002\/bdd.2510080302","volume":"8","author":"P Rohdewald","year":"1987","unstructured":"Rohdewald P, et al. Pharmacokinetics of dexamethasone and its phosphate ester. Biopharm Drug Dispos. 1987;8(3):205\u201312.","journal-title":"Biopharm Drug Dispos"},{"issue":"5","key":"11322_CR53","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1097\/00007691-199910000-00007","volume":"21","author":"GG T\u00f2th","year":"1999","unstructured":"T\u00f2th GG, et al. Pharmacokinetics of high-dose oral and intravenous dexamethasone. Ther Drug Monit. 1999;21(5):532.","journal-title":"Ther Drug Monit"},{"issue":"10","key":"11322_CR54","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.3390\/jcm10102214","volume":"10","author":"M Rubio-Rivas","year":"2021","unstructured":"Rubio-Rivas M, et al. Risk categories in COVID-19 based on degrees of inflammation: data on more than 17,000 patients from the Spanish SEMI-COVID-19 registry. J Clin Med. 2021;10(10):2214.","journal-title":"J Clin Med"},{"issue":"17","key":"11322_CR55","first-page":"3896","volume":"58","author":"M Tampellini","year":"1998","unstructured":"Tampellini M, et al. Docetaxel chronopharmacology in mice. Can Res. 1998;58(17):3896\u2013904.","journal-title":"Can Res"},{"issue":"2","key":"11322_CR56","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s42399-021-00749-y","volume":"3","author":"ZN Hatmi","year":"2021","unstructured":"Hatmi ZN. A systematic review of systematic reviews on the COVID-19 pandemic. SN Compr Clin Med. 2021;3(2):419\u201336.","journal-title":"SN Compr Clin Med"},{"issue":"7","key":"11322_CR57","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/jmv.25785","volume":"92","author":"H Cheng","year":"2020","unstructured":"Cheng H, Wang Y, Wang GQ. Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19. J Med Virol. 2020;92(7):726\u201330.","journal-title":"J Med Virol"},{"issue":"12","key":"11322_CR58","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1111\/1753-0407.13085","volume":"12","author":"A Rajpal","year":"2020","unstructured":"Rajpal A, Rahimi L, Ismail-Beigi F. Factors leading to high morbidity and mortality of COVID-19 in patients with type 2 diabetes. J Diabetes. 2020;12(12):895\u2013908.","journal-title":"J Diabetes"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11322-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11322-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11322-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T03:50:09Z","timestamp":1757476209000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11322-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,27]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11322"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11322-6","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,27]]},"assertion":[{"value":"27 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study was approved by the Institutional Review Board of Hamad Medical Corporation (Protocol number: MRC-01\u201320-145) with a waiver of informed consent under the pandemic response framework. All methods used in this study were conducted by the relevant guidelines and regulations (such as the Declaration of Helsinki).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1074"}}